Is Spravato For Me?
(esketamine)
Real Results
In a short-term study, those that received SPRAVATO® in conjunction with an antidepressant, saw a greater reduction in symptoms.
SPRAVATO® offers a different approach and is the only
FDA-approved nasal spray treatment for treatment-resistant depression (TRD)
SPRAVATO® is an NMDA receptor antagonist that is believed to work differently by acting on a pathway in the brain that affects glutamate. Glutamate is the most abundant neurotransmitter in the brain.
Ready to try?
SPRAVATO® is taken in conjunction with an oral antidepressant.
You will administer the medication yourself under the supervision of a healthcare provider at a certified SPRAVATO® treatment center.
SPRAVATO® is taken twice a week for the first four weeks. After four weeks, you and your doctor will discuss and determine if treatment should be continued, the dose to be administered and how often you should receive SPRAVATO®